Quarterly report · Q3
4978.TEDINET S100ST0T
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.8bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥3.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | −¥289m | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | −¥207m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥58m | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | −¥120m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥37m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥50m | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | −¥37m | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥48m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥305m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥39m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥48m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | −¥39m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥8.4bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥8.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥8.3bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥627m | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥781m | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.7bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥7.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.7bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.9bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥0.57 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.15 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.62 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.47 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.27 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥0.57 | 2023-04-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 92.4% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.7% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.3% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment ordinary income | 2023-04-01 → 2023-12-31 | −¥396m |
| jpcrp040300-q3r_E27585-000Medical Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥265m |
| jpcrp040300-q3r_E27585-000Medical Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥265m |
| jpcrp040300-q3r_E27585-000Medical Businessreportable segment | segment ordinary income | 2023-04-01 → 2023-12-31 | ¥190m |
| jpcrp040300-q3r_E27585-000Research Support Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E27585-000Research Support Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E27585-000Research Support Businessreportable segment | segment ordinary income | 2023-04-01 → 2023-12-31 | ¥264m |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥1.8bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥1.8bn |
| —segment total | segment ordinary income | 2023-04-01 → 2023-12-31 | ¥454m |
| Reconciling Itemsreconciling | segment ordinary income | 2022-04-01 → 2022-12-31 | −¥440m |
| jpcrp040300-q3r_E27585-000Medical Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥866m |
| jpcrp040300-q3r_E27585-000Medical Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥866m |
| jpcrp040300-q3r_E27585-000Medical Businessreportable segment | segment ordinary income | 2022-04-01 → 2022-12-31 | ¥204m |
| jpcrp040300-q3r_E27585-000Research Support Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E27585-000Research Support Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E27585-000Research Support Businessreportable segment | segment ordinary income | 2022-04-01 → 2022-12-31 | ¥200m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥2.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥2.2bn |
| —segment total | segment ordinary income | 2022-04-01 → 2022-12-31 | ¥404m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 343
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | Prior1YTDDuration | 2223277000 | JPY |
| Net sales | CurrentYTDDuration | 1776765000 | JPY |
| Cost of finished goods sold | Prior1YTDDuration | 647132000 | JPY |
| Cost of finished goods sold | CurrentYTDDuration | 635118000 | JPY |
| Cost of service operations cos | Prior1YTDDuration | 701905000 | JPY |
| Cost of service operations cos | CurrentYTDDuration | 316990000 | JPY |
| Cost of sales | Prior1YTDDuration | 1349038000 | JPY |
| Cost of sales | CurrentYTDDuration | 952108000 | JPY |
| Gross profit | Prior1YTDDuration | 874239000 | JPY |
| Gross profit | CurrentYTDDuration | 824656000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 337256000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 265290000 | JPY |
| Other selling general and administrative expenses sga | Prior1YTDDuration | 744244000 | JPY |
| Other selling general and administrative expenses sga | CurrentYTDDuration | 848692000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 1081501000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 1113983000 | JPY |
| Operating income | Prior1YTDDuration | -207261000 | JPY |
| Operating income | CurrentYTDDuration | -289326000 | JPY |
| Interest income noi | Prior1YTDDuration | 27994000 | JPY |
| Interest income noi | CurrentYTDDuration | 34808000 | JPY |
| Subsidy income noi | Prior1YTDDuration | 98733000 | JPY |
| Subsidy income noi | CurrentYTDDuration | 237319000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 5898000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 57832000 | JPY |
| Gain on investments in partnership noi | Prior1YTDDuration | 14156000 | JPY |
| Gain on investments in partnership noi | CurrentYTDDuration | － | JPY |
| Equity in earnings of affiliates noi | Prior1YTDDuration | 268000 | JPY |
| Equity in earnings of affiliates noi | CurrentYTDDuration | － | JPY |
| Other noi | Prior1YTDDuration | 24640000 | JPY |
| Other noi | CurrentYTDDuration | 26560000 | JPY |
| Non operating income | Prior1YTDDuration | 171692000 | JPY |
| Non operating income | CurrentYTDDuration | 356521000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 80000 | JPY |
| Interest expenses noe | CurrentYTDDuration | － | JPY |
| Loss on investments in partnership noe | Prior1YTDDuration | － | JPY |
| Loss on investments in partnership noe | CurrentYTDDuration | 720000 | JPY |
| Equity in losses of affiliates noe | Prior1YTDDuration | － | JPY |
| Equity in losses of affiliates noe | CurrentYTDDuration | 3825000 | JPY |
| Amortization of restricted stock compensation noe | Prior1YTDDuration | － | JPY |
| Amortization of restricted stock compensation noe | CurrentYTDDuration | 3648000 | JPY |
| Other noe | Prior1YTDDuration | 917000 | JPY |
| Other noe | CurrentYTDDuration | 732000 | JPY |
| Non operating expenses | Prior1YTDDuration | 997000 | JPY |
| Non operating expenses | CurrentYTDDuration | 8927000 | JPY |
| Ordinary income | Prior1YTDDuration | -36567000 | JPY |
| Ordinary income | CurrentYTDDuration | 58267000 | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | － | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration | 8430000 | JPY |
| Extraordinary loss | Prior1YTDDuration | － | JPY |
| Extraordinary loss | CurrentYTDDuration | 8430000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |